A Phase 1 Clinical Trial of NTQ5082 in Healthy Volunteers

Clinical trial NCT06560593 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06560593
Sponsor: Nanjing Chia-tai Tianqing Pharmaceutical
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Complement-mediated Hemolytic Diseases

Start date: 2024-08-01
Primary completion: 2024-12-01
Enrollment: 82

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.